Press releases

Oct 21, 2007

ARRIVE Registry Analysis Demonstrates Continued Safety and Efficacy of TAXUS® Stent in Complex Real-World Patients

Boston Scientific Corporation (NYSE: BSX) today announced results from an analysis of nearly 7,000 patients from its TAXUS ARRIVE 1...
Oct 19, 2007

Boston Scientific Announces Results for Third Quarter Ended September 30, 2007

Boston Scientific Corporation (NYSE: BSX) today announced financial results for the third quarter ended September 30, 2007, as well as guidance for...
Oct 17, 2007

Boston Scientific Announces New Initiatives to Increase Shareholder Value

Approximately 2,300 positions to be eliminated worldwide

Boston Scientific Corporation (NYSE: BSX) today announced several new initiatives designed to enhance short- and long-term shareholder value,...
Oct 16, 2007

Boston Scientific to Release Broad Range of Clinical Trial Data Reinforcing Safety and Efficacy of Taxus® Coronary Stent Systems at TCT 2007

Boston Scientific Corporation (NYSE: BSX) today announced the schedule of the Company's major events and press announcements at the Cardiovascular...
Oct 9, 2007

Boston Scientific Announces European Approval of Next-Generation Implantable Defibrillator

Boston Scientific Corporation (NYSE: BSX) today announced CE Mark approval of its CONFIENT™ implantable cardioverter defibrillator (ICD). This...

Show per page

Top